HIGHLIGHTS
- who: Yunhe Yu from the Patients and samples The BC inclusion criteria were as follows: (1) patients with a diagnosis of BC confirmed by the pathological report have published the research work: CircRPAP2 regulates the alternative splicing of PTK2 by binding to SRSF1 in breast cancer, in the Journal: (JOURNAL) of 21/03/2022
- how: The results showed that si-circRPAP2 exhibited high interference efficiency and that LV-circRPAP2 overexpressed circRPAP2 more than 15-fold (Fig 2A and D). Two-way analysis of variance (ANOVA) was used to analyze the MTT assay results. Comparisons between . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.